Purified Arabinogalactan-Protein (AGP) composition useful in...

Details Purified Arabinogalactan-Protein (AGP) composition useful in... Purified Arabinogalactan-Protein (AGP) composition useful in...

2004-09-01

2009-10-13

Leith, Patricia (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

C424S774000, C424S779000, C514S001000, C514S008100

Reexamination Certificate

active

07601368

ABSTRACT:
A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems ofArgemone mexicanaplant is described. Also described is a purified Arabinogalactan-Protein (AGP) composition isolated from the leaves and/or stems ofArgemone mexicanaplant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN-γ inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in Mouse Ear Swelling test (MEST).

REFERENCES:
patent: 2003/0194456 (2003-10-01), Arora et al.
patent: 01/00682 (2001-01-01), None
Wikipedia Online Encyclopedia: Argemone Mexicana; URL: <http://en.wikipedia.org/wiki/Argemone—mexicana> accessed May 30, 2007, one page.
Sukumar et al. Studies on the Leaves of Argemone Mexicana; Fitoterapia, vol. IV, No. 6, 1984, pp. 352-353.
Showalter, Am: Aribinogalactan-Proteins: Structure, Expression and Function; Cell. Mol. Life. Sci. 58 (2001) 1399-1417.
Kristian Reich et al. The Journal of Investigative Dermatology, Feb. 2 2001, 116:319-329.
G.B. Hawes, et al. “Extracellular Arabinogalactan From Suspension-Cultured Red Kindney Bean Root Cells” Phytochemistry, 1972, vol. 11, pp. 1461-1465.
Ashcroft, et al. “Systematic review of comparative eficacy and tolerability of calcipotriol in treating chronic plaque psoriasis” BMJ, 2000, 320, 963-967.
Robert S. Stern, et al. “The Carcinogenic Risk of Treatments for Severe Psoriasis” Cancer, Jun. 1, 1994, 73, 2759-2764.
R.L. Anderson, et al. “A Carbohydrate=-binding Arabinogalactan-Protein from Liquid Suspension Cultures of Endosperm fromLolium multiflorum” Aust. J. Plant Physiol., (1977), 4:143-58.
Raychaudhuri, et al., International Journal of Immunopharmacology 1999, 21; 609-615.
Krueger, et al. J Am. Aca. Dermatol. Aug. 2000, 43:281-285.
Classen, B. et al. Carbohydrate Research 327:497-504 (2000).
Fortune, et al. J. of American Academy of Dermatology 39(2) (Part 1):196-201 (1998).
Brynskov, et al. Gut, 1990, 31, 795-799.
Cornacoff, J.B., et al., Fundamental and Applied Toxicology, 1992, 19(1): 157-158.
Cornacoff, et al., Fundamental and Applied Toxicology, 1988, 10:40-44.
British National Formulary, Mar. 2000, No. 41; 522-529.
Merkle, R.K. et al. Methods in Enzymology, 1994, 230:1-15.
York, W.S., et al, Method in Enzymology, 1985, 118:3-40.
Birgit Classen, et al. “Characterization of an Arabinogalactan-Protein Isolated from Pressed Juice ofEchinacea purpureaby Precipitation with the β-Glucosyl Yariv Reagent” Carbohydrate Research (327 (2000) 497-504).
Donal G. Fortune, et al. “What Patients with Psoriasis Believe About Their Condition”, Journal of The American Academy of Dermatology, vol. 39, No. 2, Part 1((1998) pp. 196-201)).
G. Seifert et al. Annu. Rev. Plant Biol. 2007, 58, p. 137 abstract, CMLS 2001, 58, pp. 138-161.
C.J. Schultz, et al. Plant Physiology 2002, 129, pp. 1448-1463.
GMP for Botanicals, Business Horizons, 2003, p. 9 (ed. P.K. Mukherjee, et al.).
Natural Products Isolation, Humana Press, 1988, pp. 344-347 (ed. R. Cannell et al.).
Burley Curing Technology, Univ. of. Kentucky, 2004, pp. 1-6.
Showalter A.M. “Arabinogalactan-proteins: structure, expression and function” CMLS, Cell. Mol. Life Sciences 58(2001) pp. 1399-1417.
Schnippr, L. et al. “The New England Journal of Medicine” 2001 vol. 345, No. 4, pp. 284-287.
Menter, A. et al. “Current and future management of psoriasis” The Lancet, 2007 vol. 370 pp. 272-284.
Lowes, M. et al. “Pathogenesis and therapy of psoriasis” Nature 2007 vol. 445 pp. 866-873.

Affiliated with

Also associated with

Rating

Purified Arabinogalactan-Protein (AGP) composition useful in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purified Arabinogalactan-Protein (AGP) composition useful in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified Arabinogalactan-Protein (AGP) composition useful in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4135174